China Oral Industry Group Holdings Ltd
China Oral Industry Group Holdings Ltd is engaged in the pharmaceuticals industry, focusing on healthcare facilities and services, and generates revenue primarily through its operations in this sector.
Business. China Oral Industry Group Holdings Ltd (8406.HK) is a healthcare company engaged in pharmaceutical activities within the Healthcare Facilities & Services industry. The firm is listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
China Oral Industry Group Holdings Ltd (8406.HK) is a healthcare company engaged in pharmaceutical activities within the Healthcare Facilities & Services industry. The firm is listed on the Hong Kong Stock Exchange. Specific details regarding its operating segments, headquarters location, and geographic revenue mix are not available in the provided data.
The company's capital structure is characterized by a market price of 0.051 and a market cap of 83.71 million, with a price-to-book ratio of 0.87, indicating that the market value is below the book value of the company's equity. The company's liquidity is assessed as medium, with a current ratio of 2.78, suggesting it has sufficient short-term assets to cover its short-term liabilities. However, the company's net cash is negative after subtracting total debt, which raises concerns about its liquidity position.
Profitability metrics show a challenging financial position, with a return on equity of -44.17% and a return on assets of -25.7%, both significantly below the industry median. The company reported a net loss of 42.72 million and an operating loss of 43.07 million, indicating a lack of profitability. The gross profit of 14.13 million is also low relative to its revenue of 167.65 million, suggesting high cost pressures or low pricing power.
The company's revenue is not segmented by geographic regions or business lines in the available data, so it is not possible to assess revenue concentration or geographic exposure. However, the lack of segment data limits the ability to evaluate the company's diversification and risk profile.
The company's growth trajectory is uncertain, as it has reported a net loss and negative operating income. There are no specific numeric deltas provided for the current or next fiscal year, but the company's financial performance suggests a lack of growth. The company's revenue history does not indicate a clear upward or downward trend, but the negative profitability metrics suggest operational challenges.
The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights the company's liquidity constraints. The dilution risk is low, and there are no specific dilution sources or expected timeframes provided in the available data.
Recent events or filings are not detailed in the available data, so it is not possible to assess the company's recent performance or strategic direction based on disclosed events or transcripts. The lack of recent event data limits the ability to evaluate the company's current situation and future prospects.
- The company is operating at a loss, with a net income of -42.72 million and an operating income of -43.07 million.
- The company's market price is 0.051, and its market cap is 83.71 million, with a price-to-book ratio of 0.87.
- The company's return on equity is -44.17%, and its return on assets is -25.7%, both significantly below the industry median.
- The company's liquidity is assessed as medium, with a current ratio of 2.78, but it has negative net cash after subtracting total debt.
- The company's growth trajectory is uncertain, with no specific numeric deltas provided for the current or next fiscal year.
- The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- China Oral Industry Group Holdings Ltd Market data — financials · 2026-05-27
Ownership & reference
Leadership
- Ping YanExecutive Chairman of the Board
- Yao Guang LiuChief Executive Officer, Executive Director